IDIQ for cancer therapy drugs: lutathera and pluvicto

Active Indefinite Delivery Contract Awarded Last action

Contract number
W81K0024D0004
Awardee
Awarding agency
Task orders
3 $6,619,099 obligated

Award facts

Opportunity
Combined order value
$11,988,584 Current and potential, with all options
Last date to order 43% complete
IDV ceiling 25% used
$26,095,049.21
Award type
Single award
Who can order
Only the awarding agency
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

The Defense Health Agency awarded a single-award indefinite delivery contract to Novartis Pharmaceuticals Corporation, a foreign-owned large pharmaceutical manufacturer, on October 1, 2024, with a $26.1 million ceiling. No set-aside was used. The IDIQ procures LUTATHERA and PLUVICTO radiopharmaceutical cancer therapies on firm-fixed-price line items, with a period of performance running through September 30, 2029.

The requirement originated in a Department of the Army Medical Command pre-solicitation sources sought notice posted April 26, 2024, with responses due May 8, 2024. The notice cited NAICS 325412, Pharmaceutical Preparation Manufacturing, and specified quantities and treatment regimens in its salient characteristics.

The source lists Novartis's nationwide manufacturing and distribution network as place of performance: East Hanover, New Jersey (headquarters); Cary, North Carolina; Lake Mary, Florida; Phoenix, Arizona; Lebanon, Pennsylvania; Chicago, Illinois; San Antonio, Texas; West Haven, Connecticut; and Bethesda, Maryland. Delivery extends to military treatment facilities, VA medical centers, and federal healthcare beneficiary locations.

Three delivery orders have issued under this IDIQ, all from the Defense Health Agency for delivery to JBSA Fort Sam Houston, Texas. An October 1, 2024 order with a $3.39 million ceiling ran through September 30, 2025. An October 1, 2025 order of $3.23 million adjusted quantities for CLINs 0001-0004 and updated unit pricing for CLINs 0003 and 0004, with completion on September 30, 2026. An October 1, 2026 order of $5.37 million covers CLINs 2001AA and 2001AB under fixed price with economic price adjustment, with completion on September 30, 2027.

Task orders

Task order Ordering agency Obligated Awarded
Clin 2001AA and clin 2001AB W81K0026FA128 Medical Command (Army) $0
Lutathera and pluvicto W81K0025FA195 Medical Command (Army) $3,232,080
Delivery order for pluvicto and lutathera W81K0024F0177 Medical Command (Army) $3,387,020

Transactions

Action Obligated Date
Change Order P00004 · Transfer the administrative function of this contract from dodaac W81K00 to HT9408 $0
Supplemental Agreement for work within scope P00003 · Modified quantities for slins 1001AA and 1001AB for ordering period from 1 OCT 25 to 31 DEC 25 whereas slins 1001AC and 1001AD had updated unit pricing and… $0
Novation Agreement P00002 · Novation agreement $0
Funding Only Action P00001 · Lutetium LU-177 vipivotide tetraxetan $0
Original award $0

Quick answers

Who was awarded contract W81K0024D0004?

W81K0024D0004 was awarded to Novartis Pharmaceuticals Corporation by Medical Command (Department of the Army) on October 1, 2024.

How much is contract W81K0024D0004 worth?

Orders under W81K0024D0004 have obligated $6,619,099. Their combined current value, with exercised options, is $11,988,584. W81K0024D0004's own ceiling is $26,095,049.

How many orders have been placed under contract W81K0024D0004?

3 orders have been placed under W81K0024D0004, the latest on October 1, 2026.

Which agency awarded contract W81K0024D0004?

Medical Command (Department of the Army) awarded W81K0024D0004, with funding from Defense Health Agency (Department of Defense).

Who can order from contract W81K0024D0004?

W81K0024D0004 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0024D0004 competed?

The extent of competition for W81K0024D0004 was not competed. The government received 1 offer.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV